201 related articles for article (PubMed ID: 17496943)
1. Concomitant weekly vincristine and radiation followed by adjuvant vincristine and carboplatin in the treatment of high risk medulloblastoma: Ain Shams University Hospital and Sohag Cancer Center study.
Salama MM; Ghorab EM; Al-Abyad AG; Al-Bahy KM
J Egypt Natl Canc Inst; 2006 Jun; 18(2):167-74. PubMed ID: 17496943
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of concurrent carboplatin during full-dose craniospinal irradiation for high-risk/metastatic medulloblastoma in a resource-limited setting.
Gupta T; Sinha S; Chinnaswamy G; Vora T; Prasad M; Bhat V; Goda JS; Krishnatry R; Chatterjee A; Epari S; Sahay A; Moiyadi A; Shetty P; Patil V; Khatua S; Jalali R; Kurkure P
Pediatr Blood Cancer; 2021 May; 68(5):e28925. PubMed ID: 33533557
[TBL] [Abstract][Full Text] [Related]
3. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
4. Treatment of standard risk medulloblastoma with craniospinal irradiation, carboplatin, and vincristine.
Bergman I; Jakacki RI; Heller G; Finlay J
Med Pediatr Oncol; 1997 Dec; 29(6):563-7. PubMed ID: 9324345
[TBL] [Abstract][Full Text] [Related]
5. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
[TBL] [Abstract][Full Text] [Related]
6. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
7. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
Khalil EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
[TBL] [Abstract][Full Text] [Related]
8. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
Taylor RE; Bailey CC; Robinson K; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Walker DA; Pizer BL; Imeson J; Lashford LS; ;
J Clin Oncol; 2003 Apr; 21(8):1581-91. PubMed ID: 12697884
[TBL] [Abstract][Full Text] [Related]
9. Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy.
Hartsell WF; Gajjar A; Heideman RL; Langston JA; Sanford RA; Walter A; Jones D; Chen G; Kun LE
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):15-24. PubMed ID: 9300735
[TBL] [Abstract][Full Text] [Related]
10. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
[TBL] [Abstract][Full Text] [Related]
11. Adult medulloblastoma: multiagent chemotherapy.
Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
[TBL] [Abstract][Full Text] [Related]
12. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
Rutkauskiene G; Labanauskas L
Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
[TBL] [Abstract][Full Text] [Related]
13. [Role of adjuvant chemotherapy in the treatment of medulloblastoma in children].
Sachivko NV; Konoplia NE; Petrovich SV; Sharak EV
Vopr Onkol; 2002; 48(3):318-21. PubMed ID: 12455354
[TBL] [Abstract][Full Text] [Related]
14. Outcome of newly diagnosed high risk medulloblastoma treated with carboplatin, vincristine, cyclophosphamide and etoposide.
Sirachainan N; Pakakasama S; Anurathapan U; Hansasuta A; Dhanachai M; Khongkhatithum C; Jinawath A; Mahachoklertwattana P; Hongeng S
J Clin Neurosci; 2018 Oct; 56():139-142. PubMed ID: 29960842
[TBL] [Abstract][Full Text] [Related]
15. Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.
Tornesello A; Mastrangelo S; Piciacchia D; Bembo V; Colosimo C; Di Rocco C; Mastrangelo R
J Neurooncol; 1999; 45(2):135-40. PubMed ID: 10778729
[TBL] [Abstract][Full Text] [Related]
16. Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.
Jakacki RI; Burger PC; Zhou T; Holmes EJ; Kocak M; Onar A; Goldwein J; Mehta M; Packer RJ; Tarbell N; Fitz C; Vezina G; Hilden J; Pollack IF
J Clin Oncol; 2012 Jul; 30(21):2648-53. PubMed ID: 22665539
[TBL] [Abstract][Full Text] [Related]
17. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma.
Massimino M; Cefalo G; Riva D; Biassoni V; Spreafico F; Pecori E; Poggi G; Collini P; Pollo B; Valentini L; Potepan P; Seregni E; Casanova M; Ferrari A; Luksch R; Polastri D; Terenziani M; Pallotti F; Clerici CA; Schiavello E; Simonetti F; Meazza C; Catania S; Podda M; Gandola L
J Neurooncol; 2012 May; 108(1):163-71. PubMed ID: 22350379
[TBL] [Abstract][Full Text] [Related]
19. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
[TBL] [Abstract][Full Text] [Related]
20. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Saran F; Walker DA; Pizer BL; Lashford LS; ;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1184-93. PubMed ID: 15001263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
